Tag Archives: OGD

CDER Runs into Trouble with Generic Drug Reorg Plan

After less than a year on the job, the head of FDA’s Office of Generic Drugs (OGD) has announced his departure, a sign that all is not well with plans for major organizational changes at the Center for Drug Evaluation and Research (CDER).
Posted in FDA, leadership, Legal | Also tagged , , , , , , , , | Leave a comment
  • Categories

  • Meta